12 Biggest Mid-Day Losers For Monday - Dynavax Technologies (NASDAQ:DVAX)

Dynavax Technologies Corporation DVAX shares tumbled 64.9 percent to $4.07 after the disclosure of a Complete Response Letter (CRL) from the FDA on its Biologics License Application for HEPLISAV-B. The drug candidate is meant for immunization of adults 18 years and older affected by hepatitis B infection.
Resource Capital Corp. RSO shares declined 27.7 percent to $8.80. Resource Capital reported Q3 funds from operations of $12.9 million, or $42 per share.
Puma Biotechnology Inc PBYI shares fell 22.3 percent to $39.15 on Friday's KSF investigation into the company.
Turtle Beach Corp HEAR dropped 21.2 percent to $1.52. B. Riley downgraded Turtle Beach from Buy to Neutral.
JetPay Corporation JTPY declined 15.1 percent to $2.25. JetPay reported a Q3 loss of $0.16 per share on revenue of $15.21 million.
Net Element International Inc NETE shares fell 13.7 percent to $0.950. Net Element reported Q3 adjusted loss of $0.20 per share on revenue of $14.01 million.
Patriot National Inc PN declined 13.2 percent to $5.94. Patriot National posted Q3 earnings of $0.12 per share on revenue of $60.2 million.
Galena Biopharma Inc GALE dropped 12.4 percent to $3.68 after the company disclosed that data from GALE-301/GALE-302 clinical program was presented at the Society for Immunotherapy of Cancer Conference 2016.
NetSol Technologies Inc. NTWK fell 12.2 percent to $5.40. NETSOL posted a Q1 loss of $0.17 per share on revenue of $15 million.
Gold Standard Ventures Corp GSV shares declined 11.2 percent to $1.91. Gold Standard Ventures shares have jumped 298.15 percent over the past 52 weeks, while the S&P 500 index has gained 5.42 percent in the same period.
Edgewater Technology Inc. EDGW dropped 10.4 percent to $7.17 as the company reported the conclusion of formal review of strategic alternatives.
Ultragenyx Pharmaceutical Inc RARE declined 3.7 percent to $79.03. Citigroup downgraded Ultragenyx Pharmaceutical from Neutral to Sell.

Market News and Data brought to you by Benzinga APIs